Zoe Quandt

14PUBLICATIONS
113CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunogenetics (incl. genetic immunology)AutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 14, 2026
A Phase II Trial of Pembrolizumab plus Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Biliary Cancer.

|Jan 03, 2026
GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization.

Aditya Mahadevan, Aidan Vosooghi, Jagmeet S Arora

|Oct 15, 2025
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors.

Ling Zhu, Yee-Ming M Cheung, Cherie Chiang

|Aug 14, 2025
Autoimmune origin for immune checkpoint inhibitor-diabetes revealed by deep immune phenotyping of the pancreas.

Zoe Quandt, Arabella Young, Graham Larson Barlow

|May 30, 2025
The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes.

Julia K Mader, Jenise C Wong, Guido Freckmann

Pageof 3